Entry of human immunodeficiency virus type 1 (HIV-1) into T cells is mediated by the viral envelope glycoproteins gpl20 and gp4l and the CD4 host cell protein, which serves as a receptor (for reviews, see references 7, 13, and 21). HIV-1 envelope glycoproteins form the surface spikes visualized in electron micrographs of virions. Each spike represents an oligomer of gpl20 and gp4l molecules (3) . The gp4l transmembrane proteins anchor the oligomer in the viral membrane (5) . Viral entry is mediated by gpl20 binding to CD4 (for recent articles on this subject, see references 22 and 26) , putative postbinding conformational changes that expose a fusion domain at the N terminus of gp4l (2, 8, 9, 14, 19) , and fusion of viral and host cell membranes. Entry is pH independent and can occur by fusion through the cytoplasmic membrane or the membrane of an endocytic vesicle (6, 18, 20) .
Recently, we used single-cycle analyses to demonstrate that differences in the permissiveness of T-cell lines for HIV-1 NL4-3 infections are determined by differences in the permissiveness of the cells for virus entry (25) . In the highly permissive C8166 cells, 50% of the infectious units of NL4-3 escaped an antireceptor antibody block (leu3a block) within approximately 30 min of infection. In contrast, in three less permissive cell lines, H9, A3.01, and Jurkat, 50% entry required an average of 4 h. Entry efficiency correlated with entry rate, with stocks of NILA-3 having about three-timeshigher titers of infectious units on C8166 cells than on H9 cells. In each of the cell types, entry required CD4. However, the rate and efficiency of entry did not correlate with surface levels of CD4.
The current study was undertaken to further characterize steps that determine the rates with which infectious units of NILA-3 enter cells. In particular, we wished to determine the * Corresponding author.
relative time courses with which infectious units of NL4-3 escaped the ability to be blocked by the antireceptor monoclonal antibody leu3a and by a neutralizing monoclonal antibody to the third variable (V3) loop of gpl20 (for a recent article on this subject, see reference 15). Neutralizing antibody to the V3 loop does not block gpl2O-CD4 binding (23) and is thought to act by inhibiting postbinding conformational changes that are required for entry. Studies of the time course of NL4-3 escape from an anti-V3 loop antibody were undertaken with C8166 and H9 cells. These two cell lines have substantial differences in their permissiveness for NLA-3 entry (25) . A well-characterized neutralizing monoclonal antibody to the V3 loop, 0.5,B, was used to block V3 loop activity (17) .
To establish conditions that would allow us to use 0.5,B as an entry block, 0.51 concentrations of 0.02 to 20 ,ug/ml were tested for their ability to block NL4-3 entry into C8166 and H9 cells. Neutralization assays were conducted for NLA-3 that had been preincubated with 0.51 for 30 min at 37°C prior to its addition to cells as well as for virus that was not exposed to 0.51 until the time at which it was added to cells. Several concentrations of leu3a were also tested for their ability to block entry into C8166 and H9 cells. In these tests, leu3a was added to cells 10 min before the addition of virus. Both antibodies successfully blocked NL4-3 infections on C8166 and H9 cells (Fig. 1) . The concentration of 0.51 required to block entry was 100 to 1,000 times higher than that of leu3a. The efficiency of the 0.51 block was not affected by preincubating virus with antibody. Further blocking experiments were done with 20 ,g of 0.513 per ml and 250 ng of leu3a per ml. These levels of the two different antibodies achieved .80% blocking of entry within 10 min ( Fig. 1 ). By working with levels of antibody that gave similar levels of blocking, we minimized effects of differences in affinity or binding kinetics on escape times.
The with which entry could be blocked by washing cells, t adding the antireceptor antibody (leu3a block), or by addii the anti-V3 loop neutralizing antibody (0.5,B block) ( Fig. and Table 1 ). Infections were initiated with prewarmed ce] and virus in the presence of 2 ,ug of Polybrene per ml multiplicities of 0.25 C8166 infectious units per cell. various times postinfection, aliquots of infected cultur underwent one of the blocking treatments (wash, addition 250 ng of leu3a per ml, or addition of 20 ,ug of 0.51 per m At 12 to 15 h postinfection for H9 cells and 6 h for C81 cells, leu3a (250 ng/ml) and dideoxycytidine (2 ,uM) we added to the cultures to prevent the spread of progeny viri or syncytium formation, which would confuse the quantit tion of the first round of infection (25) . Successful entry w scored by determining plateau levels of virus-expressir cells by indirect immunofluorescence (assays were done >. h after infection of C8166 cells and .65 h after infection H9 cells) (25) . The time courses for escape from each of the blocks we cell line specific ( Fig. 2 and Table 1 ). The wash block, whi measures the rate of virus adsorption to cells, was the fil block to be passed, with infectious units requiring abo three times longer to adsorb to H9 than to C8166 cell Interestingly, in C8166 infections, escapes from the wa and anti-V3 loop blocks had indistinguishable time courses. This suggests that V3 loop-dependent steps in entry take place essentially simultaneously with binding in C8166 cells. In contrast, during entry into H9 cells, 50% escape from 0.51 required more than twice as long as escape from the wash. Unexpectedly, in both C8166 and H9 cells, the leu3a escape followed the 0.5,B escape. About 25 min elapsed between escape from 0.51 and escape from leu3a in C8166 cells, whereas about 80 min elapsed between these escapes in H9 cells.
To test whether the blocking pattern observed for 0.51 was a general pattern for anti-V3 loop antibodies, a polyclonal serum raised against a V3 loop peptide (RP135) in )0 goats (10) was tested for its blocking activity. A 1:40 dilution of this serum neutralized >95% of NL4-3 within 10 min. The patterns of escape from the anti-RP135 serum were very similar to those observed for 0.51 on both C8166 cells and H9 cells (data not shown). As observed with 0.51, each of the escapes preceded the leu3a escape. Thus, relatively rapid escape from anti-V3 loop antibodies appears to be a general characteristic of NL4-3 infections.
We had not anticipated that escape from the anti-V3 loop antibodies would precede escape from leu3a. The relatively rapid escape from the V3 loop blocks suggests that V3 loop function in entry is early and short-lived. This could be consistent with the hypothesis that proteolytic cleavage of the V3 loop facilitates the exposure and function of the gp4l fusion domain (2, 9, 11, 12) . In contrast, the relatively long )o periods required for leu3a escape suggest that late as well as early steps in entry require binding of gpl20 to CD4.
ti-Quantitative analyses of the ability of synthetic soluble CD4 B) to block infectivity have demonstrated that multiple gpl20lls CD4 interactions are required for the entry of a single ra-infectious unit (16) . Our results suggest that these multiple to interactions constitute a rate-limiting step in infection. One he function of multiple gp120-CD4 binding events might be the net triggering of conformational changes necessary for the fu-Fort sion step of entry. The enhancement of the infectivity of the African green monkey simian immunodeficiency virus by soluble CD4 would be consistent with this possibility (1) . A second explanation might be that fusion requires the recruitment of the gp41 proteins present in several spikes into a by single multimeric structure to form a fusion pore (24) . Such ng a multimeric structure would be consistent with the identi-2 fication of a trans-dominant mutation in the fusion domain of Ils gp4l (4 
